ACTA1 and colitis: Our results show that inhibition of PFKFB3 indeed hampers the inflammation in DSS-induced colitis, simultaneously also decreasing the number of activated/fibrotic stromal cells (highlighted by reduced levels of collagen, α-SMA, and vimentin).